The global anterior uveitis treatment market size is expected to reach USD 967.5 million by 2030, registering a CAGR of 12.6% from 2024 to 2030, according to a new report by Grand View Research, Inc. Rising prevalence of the disease is anticipated to aid market growth. This disease is more common when compared to panuveitis, posterior, and intermediate uveitis.
According to a 2017...
The global uveitis treatment market is projected for steady growth, with a market size expected to reach USD 975.6 million by 2030. This translates to a compound annual growth rate (CAGR) of 5.9% during the forecast period of 2023-2030, according to market research. This press release explores the key factors influencing this growth and examines potential challenges that may affect...
Introduction:
Uveitis, characterized by inflammation of the uvea (middle layer of the eye), poses a significant challenge in ophthalmic healthcare. The Uveitis Treatment Market has been witnessing notable developments as researchers and pharmaceutical companies strive to address the complexities associated with this ocular condition. This article delves into the current trends, key treatment...
The global uveitis treatment market, valued at USD 616.7 million in 2022, is projected to grow at a steady compound annual growth rate (CAGR) of 5.9% during the forecast period from 2023 to 2030, reaching USD 975.6 million by the end of 2030.
Uveitis is a group of inflammatory diseases that affect the uvea, the middle layer of the eye. It can lead to vision loss if not treated...